Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Sale of 75,000 MLYS shares, $1.91M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 75,000 | $1.91M |
| Jul 16, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 10,700 | $291.4K |
| Jul 7, 2026 | IMMUNIC, INC. (IMUX) | Grant/Award | 25,370 | n/a |
| Jun 30, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 58,000 | $1.50M |
| Jun 29, 2026 | IMMUNIC, INC. (IMUX) | Grant/Award | 50,740 | n/a |
| May 1, 2026 | Avalyn Pharma Inc. (AVLN) | Grant/Award | 26,978 | n/a |
| Apr 16, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 15,730 | $422.0K |
| Apr 2, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 19,364 | $493.8K |
| Feb 21, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 140,900 | n/a |
| Jan 14, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Sale | 9,119 | $293.7K |